Ambrx Biopharma Cayman, Inc. Revenues USD 2022 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Revenues history and growth rate from 2022 to 2023.
  • Ambrx Biopharma Cayman, Inc. Revenues for the quarter ending June 30, 2023 was $1.12 M, a 13.5% decline year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Revenues for 2022 was $7.4 M, a 0.71% decline from 2021.
  • Ambrx Biopharma Cayman, Inc. annual Revenues for 2021 was $7.46 M, a 45.5% decline from 2020.
  • Ambrx Biopharma Cayman, Inc. annual Revenues for 2020 was $13.7 M, a 32.6% increase from 2019.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1.12 M -$176 K -13.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $24 K -$1.59 M -98.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q2 2022 $1.3 M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.61 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.